Salzhauer Michael’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $349K | Sell |
6,053
-5,800
| -49% | -$333K | 0.12% | 68 |
|
|
2026
Q1 | $376K | Buy |
11,853
+5,800
| +96% | +$338K | 0.18% | 59 |
|
|
2025
Q4 | $326K | Hold |
6,053
| – | – | 0.13% | 68 |
|
|
2025
Q3 | $273K | Sell |
6,053
-64
| -1% | -$2.99K | 0.13% | 76 |
|
|
2025
Q2 | $283K | Hold |
6,117
| – | – | 0.17% | 66 |
|
|
2025
Q1 | $373K | Hold |
6,117
| – | – | 0.23% | 60 |
|
|
2024
Q4 | $346K | Buy |
6,117
+10
| +0.2% | +$559 | 0.18% | 61 |
|
|
2024
Q3 | $316K | Buy |
+6,107
| New | +$286K | 0.19% | 63 |
|
|
2022
Q4 | – | Sell |
-2,263
| Closed | -$161K | – | 116 |
|
|
2022
Q3 | $161K | Hold |
2,263
| – | – | 0.1% | 93 |
|
|
2022
Q2 | $174K | Sell |
2,263
-2,000
| -47% | -$152K | 0.1% | 92 |
|
|
2022
Q1 | $208K | Buy |
+4,263
| New | +$286K | 0.09% | 91 |
|
|
2020
Q1 | – | Sell |
-2,338
| Closed | -$150K | – | 114 |
|
|
2019
Q4 | $150K | Hold |
2,338
| – | – | 0.07% | 117 |
|
|
2019
Q3 | $119K | Hold |
2,338
| – | – | 0.06% | 117 |
|
|
2019
Q2 | $106K | Hold |
2,338
| – | – | 0.05% | 127 |
|
|
2019
Q1 | $112K | Hold |
2,338
| – | – | 0.05% | 129 |
|
|
2018
Q4 | $122K | Sell |
2,338
-450
| -16% | -$24.2K | 0.07% | 127 |
|
|
2018
Q3 | $173K | Hold |
2,788
| – | – | 0.07% | 150 |
|
|
2018
Q2 | $154K | Hold |
2,788
| – | – | 0.06% | 155 |
|
|
2018
Q1 | $176K | Hold |
2,788
| – | – | 0.07% | 150 |
|
|
2017
Q4 | $171K | Hold |
2,788
| – | – | 0.07% | 148 |
|
|
2017
Q3 | $178K | Buy |
2,788
+2
| +0.1% | +$117 | 0.08% | 143 |
|
|
2017
Q2 | $155K | Hold |
2,786
| – | – | 0.07% | 146 |
|
|
2017
Q1 | $152K | Hold |
2,786
| – | – | 0.07% | 145 |
|
|
2016
Q4 | $163K | Buy |
+2,786
| New | +$152K | 0.08% | 142 |
|
|
2016
Q3 | – | Sell |
-2,788
| Closed | -$205K | – | 148 |
|
|
2016
Q2 | $205K | Hold |
2,788
| – | – | 0.17% | 108 |
|
|
2016
Q1 | $178K | Hold |
2,788
| – | – | 0.15% | 115 |
|
|
2015
Q4 | $192K | Sell |
2,788
-6
| -0.2% | -$397 | 0.14% | 121 |
|
|
2015
Q3 | $165K | Buy |
+2,794
| New | +$177K | 0.13% | 117 |
|
|
2015
Q2 | – | Sell |
-2,794
| Closed | -$184K | – | 146 |
|
|
2015
Q1 | $180K | Hold |
2,794
| – | – | 0.16% | 105 |
|
|
2014
Q4 | $165K | Sell |
2,794
-6
| -0.2% | -$338 | 0.14% | 117 |
|
|
2014
Q3 | $152K | Hold |
2,800
| – | – | 0.14% | 110 |
|
|
2014
Q2 | $136K | Hold |
2,800
| – | – | 0.13% | 106 |
|
|
2014
Q1 | $145K | Hold |
2,800
| – | – | 0.14% | 106 |
|
|
2013
Q4 | $149K | Buy |
+2,800
| New | +$143K | 0.15% | 98 |
|
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Salzhauer Michael's BMY Position: Q2 2026 in Review
Salzhauer Michael reduced its Bristol-Myers Squibb (BMY) stake by 49% in Q2 2026, selling an estimated $333K and leaving 6,053 shares worth $349K. The position accounts for 0.12% of the portfolio, ranked #68.
Salzhauer Michael first reported a position in BMY in Q4 2013 and has held it in 34 quarters since. The position peaked at $376K in Q1 2026. 774 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Salzhauer Michael held 6,053 shares of Bristol-Myers Squibb worth $349K as of Q2 2026.
- Salzhauer Michael sold 5,800 Bristol-Myers Squibb shares in Q2 2026, an estimated $333K.
- Bristol-Myers Squibb made up 0.12% of Salzhauer Michael's portfolio in Q2 2026, its #68 holding.
- Salzhauer Michael first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 34 quarters since.
- Salzhauer Michael's Bristol-Myers Squibb position peaked at $376K in Q1 2026.
- 774 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Salzhauer Michael's 13F filing for Q2 2026, filed 20 Jul 2026.